市場調查報告書
商品編碼
1497542
骨質密度檢測設備市場:按類型、應用和最終用戶分類 - 全球預測 2024-2030Bone Densitometer Market by Type (Axial Bone Densitometry, Dual-energy X-Ray Absorptiometry, Peripheral Bone Densitometry), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年骨質密度檢測設備市場規模為3.2287億美元,預計2024年將達3.3807億美元,2030年將達4.4807億美元,複合年成長率為4.79%。
骨質密度檢測設備主要由可用於評估骨骼密度、診斷骨質疏鬆症和評估個人骨折風險的設備組成。這些設備利用多種技術,包括雙能量 X光檢測法(DXA)、超音波和定量電腦斷層掃描 (QCT),來量化骨礦物質含量並提供有關骨骼健康的資訊。由於世界人口老化、骨質疏鬆症盛行率增加以及患者對早期診斷和預防措施的認知不斷提高,世界各地對骨質密度檢測設備的需求不斷增加。然而,該產品成本高昂,加上骨質密度檢測設備結果存在誤差,限制了其普及。此外,政府核准新開發的產品系列的嚴格核准程序對骨質密度檢測設備的可用性產生了負面影響。市場參與企業對研發的大量投資以及先進骨質密度檢測設備的出現預計將為未來幾年骨質密度檢測設備市場提供成長機會。
主要市場統計 | |
---|---|
基準年[2023] | 3.2287億美元 |
預測年份 [2024] | 33807萬美元 |
預測年份 [2030] | 44807萬美元 |
複合年成長率(%) | 4.79% |
區域洞察
骨質密度檢測設備市場在北美和南美不斷成長,主要是在美國和加拿大等新興市場,由於人們對骨骼健康意識的提高和整形外科疾病發病率的增加,對骨質密度檢測設備的需求很高。此外,研究進展在推動市場成長方面也發揮著重要作用。在歐盟地區,骨質疏鬆症診斷和護理管理的趨勢正在推動骨質密度檢測設備設備的採用率。此外,促進預防性醫療措施的公共衛生計畫也對歐盟國家的市場成長做出了重大貢獻。然而,在中東和非洲地區,對醫療基礎設施的策略性投資和對預防性醫療保健的日益關注預計將在未來幾年促進市場成長。亞太地區骨質密度檢測設備市場正在成長,主要由中國、日本和印度推動。這些國家人口老化嚴重,面臨骨質疏鬆症和其他相關疾病的風險。由於人們對骨骼健康問題的宣導活動不斷增強,對 DXA 系統等可攜式設備的需求不斷成長。此外,政府促進診斷技術研究的措施也對該地區的市場擴張產生了重大影響。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在骨質密度檢測設備市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對骨質密度檢測設備市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該細分市場競爭力的寶貴見解,包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在骨質密度檢測設備市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[191 Pages Report] The Bone Densitometer Market size was estimated at USD 322.87 million in 2023 and expected to reach USD 338.07 million in 2024, at a CAGR 4.79% to reach USD 448.07 million by 2030.
The bone densitometer comprises devices that primarily help assess bone density, diagnose osteoporosis, and evaluate the risk of fracture in individuals. These devices utilize various technologies such as Dual-Energy X-ray Absorptiometry (DXA), ultrasound, and quantitative computed tomography (QCT) to quantify bone mineral content and accurately assess bone health. An aging global population, increasing prevalence of osteoporosis, and rising awareness about early diagnosis and prevention measures among patients have increased the need for bone densitometers worldwide. However, the high costs of products coupled with errors associated with the results of bone densitometers limit product penetration. In addition, the strict government approval procedures to approve newly developed product portfolios negatively impact the availability of bone densitometers. The significant investments by the market players in research and development and the emergence of advanced bone densitometers are expected to create growth opportunities for the bone densitometer market in the coming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 322.87 million |
Estimated Year [2024] | USD 338.07 million |
Forecast Year [2030] | USD 448.07 million |
CAGR (%) | 4.79% |
Regional Insights
The bone densitometer market is witnessing growth across the Americas, particularly in developed markets such as the United States and Canada, owing to high demand for bone densitometers due to increasing awareness about bone health and greater incidence of orthopedic conditions. Further, advances in research have also played a significant role in driving market growth. In the EU region, trends regarding osteoporosis diagnosis and care management initiatives have driven adoption rates for bone densitometer devices. Additionally, public health programs promoting preventative care measures contribute significantly to market growth in EU countries. However, with strategic investments in healthcare infrastructure and increasing focus on preventive care across the Middle East and Africa region, market growth is expected to grow in the coming years. The Asia-Pacific region is experiencing growth in the bone densitometer market, driven mainly by China, Japan, and India. These countries have a large aging population at risk for developing osteoporosis and other related conditions. The growing demand for portable devices such as DXA systems has resulted from increased awareness campaigns regarding bone health issues. Furthermore, government initiatives promoting research into diagnostic technologies have significantly impacted this market's expansion within this region.
Market Insights
The market dynamics represent an ever-changing landscape of the Bone Densitometer Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Bone Densitometer Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Bone Densitometer Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Fujitsu and iSurgery launched a bone health promotion project in Japan with Jikei University School of Medicine aiming for the early detection of osteoporosis
Fujitsu Limited and iSurgery Co., Ltd. are collaborating with the Department of Orthopaedic Surgery at Jikei University School of Medicine to conduct a field trial of their "bone health promotion project" from October 2023 to March 2025. This project aims to focus on employee bone health during examinations by utilizing chest radiographs in a novel way. The project group will utilize iSurgery's AI medical device, Chest Bone Indicator, to assess bone health from chest radiographs and inform staff members of their examination results. [Published On: 2023-09-26]
AFFIDEA Expands In Italy Through The Acquisition Of Istituto Radiologico Gandini
Affidea, a provider of diagnostic imaging, out-of-hospital, and cancer care services, has recently acquired Istituto Radiologico Gandini in Biella, Piedmont. Istituto Radiologico Gandini is renowned for its advanced diagnostic imaging services, particularly radiology and senology. The medical facility offers various innovative diagnostic technologies, including MRI, mammography, Bone Densitometry, Doppler ultrasound, and comprehensive breast check-ups. This acquisition further strengthens Affidea's commitment to delivering patients high-quality and cutting-edge diagnostic services. [Published On: 2023-05-05]
Medimaps Group Announces Partnership With OsteoSys to Bring Trabecular Bone Score to Korea's Leading Bone Densitometry Platform
MEDIMAPS GROUP, a Swiss-global med-tech company specializing in image processing software for bone health assessment, has made their Trabecular Bone Score (TBS iNsight) available on OsteoSys Co. Ltd's diagnostic platforms. OsteoSys, the Bone Mineral Densitometer brand in Korea and supplier of DXA scanning equipment worldwide, now offers TBS iNsight on their high-end DXA scanning product, Primus Whole Body DXA. This partnership aims to expand access to Medimaps' innovative technology to clinicians worldwide, including countries throughout Southeast Asia, Europe, and South America. [Published On: 2022-11-14]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Bone Densitometer Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Bone Densitometer Market, highlighting leading vendors and their innovative profiles. These include Anjue Medical Equipment, BeamMed, Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, Eurotec Systems S.r.l, FURUNO Electric Co., Ltd., GE HealthCare Technologies, Inc., Hologic, Inc., Intermedical Co.,Ltd., KWIPPED, Inc., L'acn L'accessorio Nucleare S.R.L, M-cast Inc., Medilink International Ltd., Medonica Co., Ltd., mpall Co., Ltd., Nanjing Kejin Industrial Co., Ltd., Nanoomtech Co., Ltd., Oscare Medical Oy, Osteosys Corporation, Scanflex Healthcare AB, Shenzhen XRAY Electric Co., Ltd., Swissray International, Inc., Trivitron Healthcare, Xianyang Kanrota Digital Ultrasound System, Co., Ltd., and YOZMA BMTech Co., Ltd..
Market Segmentation & Coverage